Hypha Labs, Inc.
FUNI
$0.01
$0.00-7.86%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -32.11% | -63.61% | -3.94% | -12.65% | 7.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.11% | -63.61% | -3.94% | -12.65% | 7.87% |
| Operating Income | 32.11% | 63.61% | 3.94% | 12.65% | -7.87% |
| Income Before Tax | 18.81% | 61.06% | -16.87% | 22.97% | -7,922.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.81% | 61.06% | -19.83% | 20.50% | -1,031.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.81% | 61.06% | -19.83% | 20.50% | -372.18% |
| EBIT | 32.11% | 63.61% | 3.94% | 12.65% | -7.87% |
| EBITDA | 32.50% | 63.72% | 4.42% | 13.33% | -- |
| EPS Basic | 32.65% | 68.52% | 2.56% | 37.88% | -288.46% |
| Normalized Basic EPS | 35.48% | 68.66% | 14.81% | 29.73% | 29.55% |
| EPS Diluted | 32.65% | 68.52% | 2.56% | 59.00% | -288.46% |
| Normalized Diluted EPS | 35.48% | 68.66% | 14.81% | 29.73% | 29.55% |
| Average Basic Shares Outstanding | 21.64% | 21.74% | 24.92% | 27.12% | 42.35% |
| Average Diluted Shares Outstanding | 21.64% | 21.74% | 24.92% | 27.12% | 42.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |